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Abstract Muscle LIM protein (MLP, also known as
cysteine rich protein 3 (CSRP3, CRP3)) is a muscle-
specific-expressed LIM-only protein. It consists of 194
amino-acids and has been described initially as a factor
involved in myogenesis (Arber et al. Cell 79:221–231,
1994). MLP soon became an important model for experi-
mental cardiology when it was first demonstrated that MLP
deficiency leads to myocardial hypertrophy followed by a
dilated cardiomyopathy and heart failure phenotype (Arber
et al. Cell 88:393–403, 1997). At this time, this was the first
genetically altered animal model to develop this devastating
disease. Interestingly, MLP was also found to be down-
regulated in humans with heart failure (Zolk et al.
Circulation 101:2674–2677, 2000) and MLP mutations are
able to cause hypertrophic and dilated forms of cardiomy-
opathy in humans (Bos et al. Mol Genet Metab 88:78–85,
2006; Geier et al. Circulation 107:1390–1395, 2003;
Hershberger et al. Clin Transl Sci 1:21–26, 2008;K n ö l le t
al. Cell 111:943–955, 2002; Knöll et al. Circ Res 106:695–
704, 2010; Mohapatra et al. Mol Genet Metab 80:207–215,
2003). Although considerable efforts have been undertaken
to unravel the underlying molecular mechanisms—how
MLP mutations, either in model organisms or in the human
setting cause these diseases are still unclear. In contrast,
only precise knowledge of the underlying molecular
mechanisms will allow the development of novel and
innovative therapeutic strategies to combat this otherwise
lethal condition. The focus of this review will be on the
function of MLP in cardiac mechanosensation and we shall
point to possible future directions in MLP research.
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Abbreviations
ALP Actinin associated LIM protein
BNP Brain natriuretic peptide
DCM Dilated cardiomyopathy
HDAC4 Histone deacetylases
HCM Hypertrophic cardiomyopathy
MLP Muscle LIM protein
NLS Nuclear translocation
PE Phenylephrine
PLN Phospholamban
PKC Protein kinase C
SERCA Sarcoplasmic reticulum calcium ATPase
TCAP Telethonin
Introduction
Muscle LIM protein (MLP) mutations can cause, either in
humans or transgenic animals, severe forms of cardiomy-
opathy and associated heart failure, but the underlying
molecular mechanisms remain poorly understood. In this
regard, MLP has been associated with a wide variety of
different biological processes such as cardiac and skeletal
myogenesis including cellular differentiation [3], blood
vessel remodeling [52], actin depolymerization [43], cyto-
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sensitivity [17], as well as mechanosensation [26, 27].
As diverse as its multiple functions are its different
localizations. The presence of MLP is not confined to a
single compartment; the protein can also be found at the
sarcomeric Z-disc/I-band regions of cardiac muscle in
different species such as drosophila [39], mouse [4, 6, 17,
21, 27], and humans [26]. In addition, MLP is also located
at the costamere (where β1-spectrin and zyxin interact with
MLP) [14], intercalated disc (where N-RAP interacts with
MLP) [13], M-band [14, 27] and the cytoplasm (where
MLP interacts with F-actin) [3] as well as the nucleus [2, 3,
6, 12, 27] (Table 1).
The Z-disc is regarded as one of the most complex
macromolecular structures in biology [56] and the locali-
zation of MLP at this structure has drawn considerable
attention. The majority of Z-disc constituents have un-
doubtedly important structural functions but a variety of
observations, such as the translocation of Z-disc proteins to
the nucleus and probably to the M-band and other cellular
compartments, their interaction with additional signaling
molecules such as protein kinase C (PKC) [32, 54], the pro-
hypertrophic phosphatase calcineurin [20, 21, 24] and in
particular, the observation that MLP at the Z-disc is
necessary for calcineurin activation in cardiac myocytes
[20, 21, 24] suggest additional previously unexpected
features, linking this structure to important intra- and
intercellular signal transduction pathways [33]. These
features may be achieved by the ability of Z-disc proteins
to facilitate macromolecular protein complexes via certain
protein / protein interacting modules such as LIM and/or
PDZ domains. Furthermore, it was also recently shown that
MLP co-localizes and interacts at the sarcomeric Z-disc
with histone deacetylases (HDAC4) and acetylases (PCAF)
which can affect and perturb calcium sensitivity, thus
highlighting a potential and novel role/function for this
multifunctional Z-disc protein.
MLP and mechanosensation
We initially cloned the MLP cDNA when we applied
differential display techniques to identify changes in gene
expression following brief periods of myocardial ischemia
[29]. Since our initial observation, MLP’s stress inducibility
has been confirmed by a variety of different groups using
different in vivo and in vitro experimental settings such as
lengthening and shortening contractions [31], mechanical
stimulation after Botulinum neurotoxin-A injection [51],
fatiguing jumping exercise [35], as well as stretch of
smooth muscle cells [9].
It was also demonstrated that overexpression of β-
receptor kinase 1 inhibitor in the MLP-deficient back-
ground resulted in the prevention of heart failure [46]. In
another approach, also related to an intervention in β-
receptor mediated signaling, phospholamban (PLN) was
ablated in MLP
−/− animals and, similar to the previous
study, a complete rescue effect was observed [41]. The
stunning improvement of function in these double trans-
genic mouse models is not solely due to improved calcium
metabolism because MLP-deficient animals exhibit normal
or enhanced sacroplasmic reticulum calcium ATPase
(SERCA) function [50] and PLN phosphorylation was also
found to be significantly increased in MLP
−/− animals [1],
Table 1 MLP (CRP3, CSRP3) interacting proteins
Protein name Localization Situation where interaction was studied Reference
Alpha actinin Z-disc Avian smooth muscle Louis et al. [37]
Telethonin (TCAP) Z-disc Cardiac muscle Knöll et al. [26]
Cofilin 2 Z-disc Cardiac and skeletal muscles Papalouka et al. [43]
HDAC4 Z-disc, I- and A-band of sarcomere Papillary muscles and or skinned fibers Gupta et al. [17]
PCAF Z-disc, I- and A-band of sarcomere Papillary muscles and/or skinned fibers Gupta et al. [17]
Zyxin Costamere In vitro Louis et al. [37]
β1 spectrin Costamere Cardiac muscle Flick et al. [14]
Integrin linked kinase (ILK) Costamere In vitro Postel et al. [45]
Z-disc
N-RAP Intercalated disc In vitro Ehler et al. [13]
MyoD Nucleus In vitro Kong et al. [30]
MRF4 Nucleus In vitro Kong et al. [30]
myogenin Nucleus In vitro Kong et al. [30]
F-actin Cytoplasm Cell culture C2C12 Arber et al. [2]
D-Lactate dehydrogenase Mitochondria Skeletal muscle Flick et al. [15]
The table lists MLP interacting proteins, their compartmental localization as well the situations where the interactions were studied
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for example defects in mechanosensation, mechanotrans-
duction, calcium sensitivity, and/or changes in passive
myocardial stiffness may account for the rescue effect.
Another important finding is that MLP
−/− animals were
born in the expected Mendelian frequencies, as such MLP
is dismissible during embryonic development but essential
for adaptation of the heart to increased hemodynamic
demands after birth, where MLP-deficient animals begin
to develop heart failure and, depending on the genetic
background, develop also significant lethality. In this
regard, MLP
−/−-isolated cardiomyocytes are defective upon
mechanical stimulation in brain natriuretic peptide (BNP)
induction, which is an important indicator of cell stretch,
whereas endothelin 1 or phenylephrine (PE) were still able
to induce BNP expression in these cells [26], pointing to a
potential role of MLP further upstream in the signal
transduction cascade. A similar defect in BNP gene
expression following stretch in an in vitro cell culture
s y s t e mh a sa l s ob e e no b t a i n e dw h e nt h eW 4 R - M L P
mutation, observed in human individuals affected by
cardiomyopathy and heart failure, has been analyzed in a
knock-in mouse model [27] or when MLP mediated nuclear
translocation was inhibited by the use of a synthetic nuclear
localization signal (NLS) peptide in neonatal rat cardio-
myocytes stretched for 48 h at 1 Hz and 10% maximal
strain [7] or under in vivo conditions in MLP heterozygous
animals after myocardial infarction [21].
MLP has multiple binding targets and is also able to bind
to telethonin (TCAP), a 167 amino-acids protein known to
interact with the amino terminal titin at the sarcomeric Z-
disc [56]. In this regard, we observed loss of telethonin at
the Z-disc in a subset of MLP
−/− cardiomyocytes as well as
in myocardial biopsies from patients carrying the W4R-
MLP mutation, which is supported by our finding that
W4R-MLP binds with less affinity to telethonin [26, 27].
Interestingly, this Z-disc defect is also completely rescued
in the MLP/PLN double knockout animals supported by
electron microscopy and immuno-histochemistry analysis
[26]. Although loss of telethonin at the sarcomeric Z-disc is
a specific effect and was not observed after myocardial
infarction or in other Z-disc protein knockout models such
as the actinin associated LIM protein (ALP) knockout
mouse [44], it should be noted that loss of telethonin in a
subset of myofibers in neurogenic disorders has been
observed as well [48], as such there is a possibility that
additional factors and/or pathologies might provoke loss or
translocation of telethonin.
Another important aspect was the significant defect in
passive elasticity under MLP deficiency, which is probably
responsible for the diastolic dysfunction observed in these
animals before they develop global heart failure. This
defect is well documented, either in isolated papillary
muscles [26] or whole hearts from 2-week-old MLP-
deficient animals [36]. Moreover, although adult MLP
deficient animals have a stiffer stress–strain relationship,
chamber compliance increased as a function of dilatation,
which suggests that systolic function in the MLP knockout
animals may temporarily improve as a result of alterations
in chamber compliance, which is mediated by dilation. In
other words, a balance may exist between exploiting the
Frank–Starling mechanism and altering chamber compli-
ance that maintains function in the absence of hypertrophic
growth. This mechanism may initially be compensatory but
may, over time, result in maladaptation [11]. Interestingly, a
defect in muscle stiffness (rigidity which can affect
excitation-contraction coupling) has also been observed in
the W4R-MLP knock in animals and which suggests a
direct functional link of MLP, possibly via telethonin, to
titin [26, 27, 36]. It remains to be elucidated whether
changes in skeletal muscle passive elasticity are associated
with adaptive or maladaptive events. The underlying
molecular mechanisms remain unclear, changes in titin
isoform gene expression as well as changes in titin
posttranslational modifications or of other known or even
unknown genes may account for the observed effects. It
will be interesting to analyze, in addition, whether the
sarcomeric Z-disc itself affects passive stiffness. However,
given the presence of MLP in the cytoplasm—and possibly
its direct interaction with I-band titin—MLP might well
have direct but so far not well-studied effects on titin’s
passive elasticity.
Based on these observations, it was suggested that the
primary defect in MLP deficient animals is not located in
the downstream pathway for gene induction but rather in
the initial sensing process of the stretch stimulus. Thus,
MLP was suggested to be part of a macromolecular cardiac
mechanical stretch sensor.
Besides its Z-disc location, MLP has also been observed
at the costameres (focal adhesions), the areas where force
generating sarcomeres are coupled with the sarcolemma
[25], and where MLP might be able to interact with its
aminoterminal LIM1 domain to β1 spectrin and with its
carboxyterminal LIM2 domain to α actinin [14]. Hence,
MLP would be perfectly suited there, in addition to its Z-
disc localization, to serve as a mechanosensor and/or to
perform similar functions like zyxin. Zyxin is also a LIM
protein, located at focal adhesions, known to interact with
MLP (Table 1,F i g .1) and able to function as a
mechanotransducer and transcription factor—at least in
endothelial cells (Table 1, Fig. 1)[ 37, 53].
MLP contains several potential phosphorylation sites
and might, at the costamere as well as at the Z-disc
region, probably also interact with integrin linked kinase
(ILK) [28, 45], an integrin-binding protein with important
functions in mechanosensation, particularly in fibroblasts
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interact with a variety of other factors present at the
costameres such as integrins, focal adhesion kinase, and
Src kinase. Src kinase, similar to ILK, also has been
shown to have an essential role in mechanosensation by
phosphorylating p130Cas [19, 47], however, at present,
the link between MLP and its ability to interact with ILK
and/or Src kinase is less understood and has not been
investigated in detail.
MLP is probably present in two different molecular
forms [6]: Firstly, the oligomeric form, which is present at
the sarcolemma and the cytoskeleton and the monomeric
form, which was found exclusively in the nucleus.
Interestingly, after myocardial infarction and pressure
overload in animals and in failing human hearts, nuclear
MLP levels in the myocardium increased at the expense of
non-nuclear MLP. In failing human hearts, almost no MLP
was detectable outside the nucleus. Evidence for nucleo-
cytoplasmic shuttling of MLP on the basis of its nuclear
NLS was also provided [7]. Here the authors used cell-
permeable synthetic peptides containing the nuclear local-
ization signal (RKYGPG) of MLP and were able to inhibit
any further shuttling of this protein, thus clearly document-
ing functionality of this NLS. In addition, inhibition of
nuclear translocation prevented the increased protein
accumulation usually seen under phenylephrine treatment
of isolated cardiomyocytes, indicating a vital role of MLP
in the control of hypertrophy after agonist stimulation.
Interestingly, cyclic strain of myocytes after prior NLS
treatment resulted in disarrayed sarcomeres, an important
Fig. 1 Schematic diagram of MLP shuttling between compartments.
This is an over-simplified diagram depicting the location of MLP at
the costameres, Z-discs as well in the nucleus. The left side indicates
as well a possible timescale after a stimulus. ms milliseconds, sec
seconds, min minutes, h hours; α, β ntegrins
138 Pflugers Arch - Eur J Physiol (2011) 462:135–142observation that can probably be compared to the in vivo
situation [4].
MLP does not contain a DNA-binding domain and thus
cannot directly bind DNA, but might be able to bind to and
affect important cardiac transcription factors such as
GATA4, GATA6, AP1 or serum response factor (SRF). It
has in fact been shown previously, that CSRP2, which is
closely related to MLP (CSRP3), can bind GATAs and SRF
and synergistically enhance gene expression in smooth
muscle cells [10]. By linking different transcription factor
complexes, LIM proteins of the CSRP family may integrate
the activities of multiple nuclear regulatory proteins to
coordinate gene-expression. MLP may also facilitate
nucleo-cytoplasmic shuttling of its non-nuclear target
calcineurin, which has been demonstrated to translocate to
the nucleus in hypertrophied cardiac myocytes [18]. In this
context it was recently shown, that MLP was the most
differentially expressed transcriptional regulator when two
different animal crosses (i.e. Piedmontese myostatin
mutants × Hereford versus Wagyu × Hereford) were
analyzed, pointing to a potential role of MLP in the
inhibition of muscle growth and thus (possibly) to a
protective function of MLP [23].
Because MLP can be found in the nucleus following
b i o m e c h a n i c a ls t r e s si nv i v oa sw e l la si nv i t r o[ 6, 7, 12]
and because MLP mutations have effects on its Z-disc and
nuclear localization [27] it might well be of interest to
analyze precisely which MLP pool shuttles into the
nucleus and whether all of these different MLP pools are
able to exchange information with the nuclear or other
compartments. Further investigations on posttranslational
modification such as phosphorylation, sumoylation, or
acetylation and their potential effects on nuclear or any
other translocation and which kinases and/or phosphatases
are at play would provide further insight on the diverse
roles of MLP.
For example, MLP is acetylated within its NLS on
position K69 [17], a modification thought to affect calcium
sensitivity and which might potentially be able to affect
MLP’s nuclear-cytoplasmic shuttling. As such, it might be
important to examine the effects of human mutations on
nuclear or any other localization and to analyze their ability
to activate a specific gene program. In particular, the K69R-
MLP mutation, found in an individual affected by DCM
and endocardial fibroelastosis [42] might well have effects
on both: calcium sensitivity and nuclear translocation.
Of equal importance is probably the observation that loss
of MLP is associated with a severe spontaneous cardiac
phenotype but only very mild skeletal muscle abnormality
[5]—similar observations also have been made in the W4R-
MLP knock in animals [27]. Nevertheless, it might be
important to examine whether MLP mutations are as well
associated with muscular dystrophy in patients. Analyzing
which pathways are activated in skeletal muscle to prevent
the onset of severe muscle disease in the MLP deficient
animals might also be a possible step towards a better
understanding of the diverse functions of MLP. Although
important pioneering studies on MLP in smooth muscle
cells have been performed [9, 52], the role of MLP in the
vasculature remains enigmatic. Last but not least, MLP
might also be linked more directly to β-adrenergic
signaling, but this link has also not been analyzed in detail.
Summary and conclusions
The heart and particular cardiomyocytes are dynamic
structures, contracting and relaxing on a constant basis.
As such, they have to respond quickly and continuously to
hemodynamic and environmental changes but the underly-
ing molecular mechanisms which lead to a “form of
constant self re-newal” remain poorly defined, particularly
because the heart has developed several different strategies
to cope with the problem of mechanosensation and
mechanotransduction.
Therefore, it is not too surprising that since our initial
description of the involvement of MLP in cardiac mecha-
nosensation, additional intra-sarcomeric mechanosensitive
signal transduction pathways have been described. Titin
contains specific elastic domains within its I-band region
(such as the N2B, PEVK and Ig domains) and proteins such
as FHL1 [49] or muscle ankyrin repeat proteins such as
CARP [40] might be able to bind to these domains and as
such participate in constituting a sarcomeric length sensor.
Heart failure is quite often associated with increased
fibrosis and hence an increase in cell/muscle stiffness
which can be counterbalanced by changes in titin-
mediated intracellular passive elasticity and MLP might
well be in a position to transmit information from the
costamere to the Z-disc and/or directly to titin as well as
into the nucleus. In addition to this, titin contains at its
M-band region another mechanosensitive element, its
kinase domain which interacts with the zinc finger
protein nbr1, with p62 and MuRF 2, a RING-B-box E3
ligase which translocates into the nucleus upon mechan-
ical inactivity [34].
In this regard, MLP is a small but multifunctional
protein and localized in different cellular compartments.
MLP can be post translationally modified and may well
be able to fulfill multiple important functions in parallel.
Available evidence from several independent groups
supports a function of MLP as part of a macromolecular
mechanosensitive signalosome and for a role of MLP as
a signal transducer.
MLP may be able to influence cardiac mechanosensa-
tion via its location at the sarcomeric Z-disc, where it
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costameres (focal adhesions) where it may respond
rapidly to changes in muscle length caused by cell/
extracellular matrix interactions. However, the precise
role and mechanism of MLP in these processes still
remains elusive (please see Fig. 1).
In this regard, the identification of novel MLP-
interacting proteins might provide new insights into MLP
function. Although the translocation of MLP into the
nucleus is well studied, its function in the nucleus is not
completely understood. MLP almost certainly undergoes
posttranslational modifications but our knowledge here
remains also limited. As pointed out earlier, MLP is
associated with changes in cardiac or skeletal passive
stiffness—again the underlying molecular events remain
poorly defined. It is also unclear as to why MLP deficiency
is associated with a severe cardiomyopathy phenotype but
only mild skeletal muscle pathology. Another interesting
feature is the effect of MLP on calcium sensitivity, which
remains also unclear.
In conclusion, MLP might have different functions and
one possible scenario might be that this molecule serves as
part of one or even several different mechanosensitive
macromolecular signalosomes. One of these complexes
might be located at the costameres, where this protein
interacts with ILK, zyxin, β1 spectrin and α actinin and
might be involved in length sensation. Another complex
might be located at the sarcomeric Z-disc, where MLP
might be involved in the sensation of tension.
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